The plant will use Emefcy’s proprietary Membrane Aerated Biofilm Reactor (MABR) wastewater treatment system.
Emefcy and TTV will build the plant at the EPRI 1 condominium complex in Addis Ababa. The plant will treat half the wastewater from this complex of 32 buildings and 7000 residents, replacing the current unreliable septic tanks with onsite wastewater recycling to irrigate the neighbourhood’s landscaping.
Based on the current design specification, the MABR-based system will treat 185 000 litres per day; and is scheduled to be commissioned in Q3 this year.
The contract will generate revenue of approximately US$400 000 for Emefcy.
“This Emefcy plant is a model for the benefits we can deliver for the people of Ethiopia. At a low cost, untreated sewage can be turned into high-quality recycled water,” said Ilan Wilf, Emefcy’s vice president of sales. “Existing septic systems throughout the country are often unreliable, overflowing and not environmentally friendly. In Addis Ababa alone, existing plants treat less than 10% of the estimated wastewater, resulting in the discharge of much untreated sewage. The Emefcy MABR solution can improve quality of life by protecting the local living environment while creating a low-cost supply of water for non-consumption uses.”
TTV and Emefcy are also working together on a wastewater treatment plant at Ayder Hospital, Mekele University in Tigray, Ethiopia, which is now under construction.
